Literature DB >> 33725974

Relationship between thrombomodulin gene polymorphism and susceptibility to venous thromboembolism: A protocol for systematic review and meta-analysis.

Meihao Wei1, Xiaohui Xue1, Yipeng Pan2, Yan Wu3.   

Abstract

BACKGROUND: Previous studies displayed that thrombomodulin gene polymorphisms are closely associated with venous thromboembolism (VTE), while the results are inconsistent. Therefore, we conducted a meta-analysis to accurately determine the association between thrombomodulin gene polymorphism and the risk of VTE.
METHODS: Wanfang, Chinese Biomedical Literature Database, Chinese National Knowledge Infrastructure, the Chongqing VIP Chinese Science and Technology Periodical Database, PubMed, EmBase, and Web of Science databases were searched, and the time to build the database was set until January 2021. The association between thrombomodulin gene polymorphism and the risk of VTE was evaluated. Meta-analysis was performed with STATA 16.0 software, and the odds ratio and its 95% confidence interval were applied to estimate the relationship between thrombomodulin gene polym'orphism and the risk of VTE.
RESULTS: The results of this meta-analysis will be submitted to a peer-reviewed journal for publication.
CONCLUSION: This meta-analysis will summarize the relationship between thrombomodulin genepolymorphism and VTE risk. ETHICS AND DISSEMINATION: Ethical approval was not required for this study. The systematic review will be published in a peer-reviewed journal, presented at conferences, and shared on social media platforms. This review would be disseminated in a peer-reviewed journal or conference presentations. OSF REGISTRATION NUMBER: DOI 10.17605/OSF.IO/UEHJP.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33725974      PMCID: PMC7982147          DOI: 10.1097/MD.0000000000025001

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


  31 in total

1.  Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses.

Authors:  Andreas Stang
Journal:  Eur J Epidemiol       Date:  2010-07-22       Impact factor: 8.082

Review 2.  Predicting the risk of recurrent venous thromboembolism (VTE).

Authors:  Michael B Streiff
Journal:  J Thromb Thrombolysis       Date:  2015-04       Impact factor: 2.300

Review 3.  Risk Factors for Cerebral Venous Thrombosis.

Authors:  Suzanne M Silvis; Saskia Middeldorp; Susanna M Zuurbier; Suzanne C Cannegieter; Jonathan M Coutinho
Journal:  Semin Thromb Hemost       Date:  2016-06-06       Impact factor: 4.180

4.  Thrombomodulin gene polymorphisms or haplotypes as potential risk factors for venous thromboembolism: a population-based case-control study.

Authors:  John A Heit; Tanya M Petterson; Whyte G Owen; James P Burke; Mariza DE Andrade; L Joseph Melton
Journal:  J Thromb Haemost       Date:  2005-04       Impact factor: 5.824

5.  In vitro functional testing of endothelial progenitor cells that overexpress thrombomodulin.

Authors:  John D Stroncek; Yujing Xue; Nabila Haque; Jeffrey H Lawson; William M Reichert
Journal:  Tissue Eng Part A       Date:  2011-05-25       Impact factor: 3.845

6.  Common genetic risk factors for venous thrombosis in the Chinese population.

Authors:  Liang Tang; Hua-Fang Wang; Xuan Lu; Xiao-Rong Jian; Bi Jin; Hong Zheng; Yi-Qing Li; Qing-Yun Wang; Tang-Chun Wu; Huan Guo; Hui Liu; Tao Guo; Jian-Ming Yu; Rui Yang; Yan Yang; Yu Hu
Journal:  Am J Hum Genet       Date:  2013-01-17       Impact factor: 11.025

7.  Prospective study of the A455V polymorphism in the thrombomodulin gene, plasma thrombomodulin, and incidence of venous thromboembolism: the LITE Study.

Authors:  N Aleksic; A R Folsom; M Cushman; S R Heckbert; M Y Tsai; K K Wu
Journal:  J Thromb Haemost       Date:  2003-01       Impact factor: 5.824

Review 8.  Thrombomodulin.

Authors:  H Weiler; B H Isermann
Journal:  J Thromb Haemost       Date:  2003-07       Impact factor: 5.824

9.  Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation.

Authors:  Larissa Shamseer; David Moher; Mike Clarke; Davina Ghersi; Alessandro Liberati; Mark Petticrew; Paul Shekelle; Lesley A Stewart
Journal:  BMJ       Date:  2015-01-02

10.  Pulmonary embolism incidence and fatality trends in chinese hospitals from 1997 to 2008: a multicenter registration study.

Authors:  Yuanhua Yang; Lirong Liang; Zhenguo Zhai; Hangyong He; Wanmu Xie; Xiaoxia Peng; Chen Wang
Journal:  PLoS One       Date:  2011-11-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.